In another study conducted with children with Type 1 diabetes, the use of another TNF-α-blocking drug etanercept showed similar favorable effects on the pancreas.22 Thus, these findings may support why GLM may be a favorable therapeutic in case of AP and AP-related pancreatic complications. Here, TNF is linked to type 1 diabetes mellitus.